Methylene blue cell viability assays performed on human breast carcinoma (MDA-MB-231) and lung carcinoma (H1703) cells exposed to increasing amounts of free TRAIL, bare NPs, and the two nanovectors evidence an improved apoptotic effect with the last-named. The gene discussed is TNFSF10; the disease is breast carcinoma.